SCOTTSDALE, ARIZONA -- (MARKET WIRE) -- August 30, 2006 -- Holmes Biopharma, Inc. (OTCBB: HLMB) announced that it has completed a one million dollar (US$1,000,000) financing with a private US based foundation. All of the funds have been advanced to the company under the terms of a convertible debenture agreement with a term of fifteen months and conversion right at one dollar (US$1.00) per share.
